Skip to main content
. 2022 Oct 25;12:887383. doi: 10.3389/fonc.2022.887383

Table 1.

Clinical data of patients in the R and NR groups.

Characteristic R group (n = 16) NR group (n = 8) P value
Gender 1.000
 Male 10 5
 Female 6 3
age 0.362
 <65 13 5
 ≥65 3 3
ECOG 0.249
 0–1 15 6
 ≥2 1 2
Smoking history 0.388
 Current or former 8 2
 Never 8 6
Antibiotic use 1.000
 In ≤1month 3 2
 No 13 6
Metastasis number 1.000
 number<2 12 6
 number≥2 4 2
CNS metastasis 0.536
 yes 2 0
 no 14 8
Liver metastasis 0.065
 yes 2 0
 no 14 8
Lung metastasis 0.621
 yes 5 1
 no 11 7
Bone metastasis 0.363
 yes 4 4
 no 12 4
PD-L1 expression 0.191
 <1% 3 4
 ≥1% 12 3
 unknown 1 1
TMB 0.095
 <10m/Mb 5 6
 ≥10m/Mb 6 0
 unknown 5 2
Lymphocyte number 0.167
 <0.8*109/L 3 4
 ≥0.8*109/L 13 4
LDH 1.000
 <250U/L 11 5
 ≥250U/L 5 3
Treatment lines 0.741
 1 7 5
 1~2 5 2
 ≥3 4 1